About Arbela Laboratories
Arbela Laboratories is a private company based in Randolph, New Jersey, incorporated in 2020 in Delaware. It has reported $575,000 raised in one offering on Form D since April 2024. Its chief executive is Michael LoCascio.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2024 | Apr 1, 2024 | $575,000of $1.5M target | 12 | $47,917 | EquityRule 504, Rule 506(b), 4a5 | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Arbela Laboratories's Form D filed Apr 1, 2024.
ML
Michael LoCascio
CEO and director